サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1541074

蛍光in situハイブリダイゼーションプローブ市場レポート：タイプ、プローブタイプ、技術、用途、エンドユーザー、地域別 2024-2032

Fluorescent in Situ Hybridization Probe Market Report by Type, Probe Type, Technology, Application, End-User, and Region 2024-2032

出版日
発行
IMARC
ページ情報
英文 137 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
蛍光in situハイブリダイゼーションプローブ市場レポート：タイプ、プローブタイプ、技術、用途、エンドユーザー、地域別 2024-2032
出版日: 2024年08月10日
発行: IMARC
ページ情報: 英文 137 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の蛍光in situハイブリダイゼーション（FISH）プローブ市場規模は、2023年に8億7,290万米ドルに達しました。今後、IMARC Groupは、市場は2032年までに15億1,270万米ドルに達し、2024年から2032年の間に6.1%の成長率（CAGR）を示すと予測しています。遺伝性疾患の有病率の増加、疾患の早期発見とスクリーニングの重視の高まり、広範な研究開発（R&D）活動は、市場を推進する主な要因の一部です。

蛍光in situハイブリダイゼーション（FISH）プローブは、細胞や組織内の特定のデオキシリボ核酸（DNA）またはリボ核酸（RNA）配列を可視化し、マッピングするために使用される分子生物学的手法です。FISHプローブは、オリゴヌクレオチド、蛍光色素、リンカーやスペーサー、ブロッキング試薬、ハイブリダイゼーションバッファーなど様々な材料から構成されています。FISHプローブは、染色体異常検出、遺伝子コピー数変動解析、腫瘍学研究、微生物同定、遺伝子発現解析、出生前診断などに広く用いられています。FISHプローブは高感度で高分解能であるため、コピー数の少ない標的配列も検出することができます。

FISHプローブは個々の患者の遺伝子プロファイルに関する貴重な洞察を提供し、特定の遺伝子変化に基づいたオーダーメイドの治療戦略を可能にするためです。さらに、遺伝子異常に関する高解像度の視覚的・定量的情報を提供するため、臨床医や研究者がFISHプローブを広く利用していることも、市場成長の原動力となっています。さらに、先進的な診断検査の費用を患者に払い戻し、質の高いヘルスケア施設へのアクセスを提供するために、いくつかの政府が支援政策を実施していることが、市場の成長を強化しています。その他の要因としては、高齢者人口の増加、ヘルスケア産業の急速な拡大、広範な研究開発（R&D）活動、標的治療への注目の高まり、高度なFISHプローブの開発への投資の増加などが挙げられ、市場成長の原動力になると予想されます。

蛍光in situハイブリダイゼーション（FISH）プローブ市場動向と促進要因：

遺伝性疾患の増加

FISHプローブは、欠失、重複、逆位、転座などの遺伝性疾患に伴う構造異常の検出に広く使用されています。さらに、標準的な顕微鏡では検出が極めて困難な微小欠失症候群や微小重複症候群の診断にも重要な役割を果たしています。さらに、FISHプローブは反復拡大を検出することができ、ハンチントン病、脆弱X症候群、筋強直性ジストロフィーの同定に役立ちます。これとは別に、FISHプローブは遺伝子コピー数の変化を評価することができるため、医療従事者の疾病分類、治療効果の予測、個別化治療の決定に役立ち、ひいては市場の成長に寄与しています。さらに、FISHプローブは保因状態に関する情報を提供するため、個人は十分な情報に基づいた生殖に関する決定を下し、適切な遺伝カウンセリングを受けることができます。

疾患の早期発見とスクリーニングの重要性の高まり

FISHプローブは、遺伝子の増幅、欠失、転座、染色体再配列など、さまざまながんによく見られる特定の遺伝子変化を標的とすることができるため、がんの早期発見と診断において重要な役割を果たしています。これとは別に、寄生虫、細菌、ウイルスによる感染症の早期診断にも応用されています。さらに、FISHプローブは、ダウン症候群、ターナー症候群、デュシェンヌ型筋ジストロフィーなどの遺伝的疾患の適時検出にも広く使用されています。さらに、発育中の胎児の染色体異常を検出する出生前診断にも広く使用されており、これにより両親は妊娠や医療介入の可能性について十分な情報を得た上で決断することができます。

広範な研究開発（R&D）活動

マルチプレックスFISHプローブのイントロダクションは、1つのサンプル内で複数の遺伝子ターゲットを同時に検出することを可能にし、研究者や臨床医が1回の実験で複数のゲノム領域を分析することを可能にするため、時間とリソースを節約することができ、市場成長にプラスの影響を与えています。さらに、最近のプロキシミティFISHプローブの市場開拓は、細胞または組織サンプル内の2つ以上の遺伝的標的間の空間的近接を検出することを可能にし、その結果、細胞内の空間的相互作用、遺伝子クラスター、クロマチン組織に関する貴重な情報を提供することができ、市場成長に寄与しています。さらに、FISHプローブデータの急速なデジタル化により、データの共有が強化され、自動画像解析、保存、リモートアクセスが可能になり、市場の成長を支えています。

目次

第1章 序文

第2章 調査範囲と調査手法

  • 調査の目的
  • ステークホルダー
  • データソース
    • 一次情報
    • 二次情報
  • 市場推定
    • ボトムアップアプローチ
    • トップダウンアプローチ
  • 調査手法

第3章 エグゼクティブサマリー

第4章 イントロダクション

  • 概要
  • 主要業界動向

第5章 世界の蛍光in situハイブリダイゼーションプローブ市場

  • 市場概要
  • 市場実績
  • COVID-19の影響
  • 市場予測

第6章 市場内訳：タイプ別

  • DNA
    • 市場動向
    • 市場予測
  • RNA
    • 市場動向
    • 主な種類
      • mRNA
      • マイクロRNA
      • その他
    • 市場予測

第7章 市場内訳：プローブタイプ別

  • 遺伝子座特異的プローブ
    • 市場動向
    • 市場予測
  • アルフォイド/セントロメア反復プローブ
    • 市場動向
    • 市場予測
  • 全染色体プローブ
    • 市場動向
    • 市場予測

第8章 市場内訳：技術別

  • フローフィッシュ法
    • 市場動向
    • 市場予測
  • Qフィッシュ法
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第9章 市場内訳：用途別

  • がん
    • 市場動向
    • 市場予測
  • 遺伝性疾患
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第10章 市場内訳：エンドユーザー別

  • 調査機関
    • 市場動向
    • 市場予測
  • 診断センター
    • 市場動向
    • 市場予測
  • その他
    • 市場動向
    • 市場予測

第11章 市場内訳：地域別

  • 北米
    • 米国
    • カナダ
  • アジア太平洋地域
    • 中国
    • 日本
    • インド
    • 韓国
    • オーストラリア
    • インドネシア
    • その他
  • 欧州
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • スペイン
    • ロシア
    • その他
  • ラテンアメリカ
    • ブラジル
    • メキシコ
    • その他
  • 中東・アフリカ
    • 市場動向
    • 市場内訳：国別
    • 市場予測

第12章 SWOT分析

  • 概要
  • 強み
  • 弱み
  • 機会
  • 脅威

第13章 バリューチェーン分析

第14章 ポーターのファイブフォース分析

  • 概要
  • 買い手の交渉力
  • 供給企業の交渉力
  • 競合の程度
  • 新規参入業者の脅威
  • 代替品の脅威

第15章 価格指標

第16章 競合情勢

  • 市場構造
  • 主要企業
  • 主要企業のプロファイル
    • Abnova Corporation
    • Agilent Technologies Inc.
    • Biocare Medical LLC
    • Biosearch Technologies（LGC Ltd.）
    • Creative Biolabs
    • F. Hoffmann-La Roche Ltd（Roche Holding AG）
    • Genemed Biotechnologies Inc.（Sakura Finetek USA Inc.）
    • Merck KGaA
    • Oxford Gene Technology（Sysmex Corporation）
    • PerkinElmer Inc.
    • ThermoFisher Scientific Inc.
図表

List of Figures

  • Figure 1: Global: Fluorescent in Situ Hybridization Probe Market: Major Drivers and Challenges
  • Figure 2: Global: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018-2023
  • Figure 3: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by Type (in %), 2023
  • Figure 4: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by Probe Type (in %), 2023
  • Figure 5: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by Application (in %), 2023
  • Figure 7: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by End-User (in %), 2023
  • Figure 8: Global: Fluorescent in Situ Hybridization Probe Market: Breakup by Region (in %), 2023
  • Figure 9: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 10: Global: Fluorescent in Situ Hybridization Probe (DNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 11: Global: Fluorescent in Situ Hybridization Probe (DNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 12: Global: Fluorescent in Situ Hybridization Probe (RNA) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 13: Global: Fluorescent in Situ Hybridization Probe (RNA) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 14: Global: Fluorescent in Situ Hybridization Probe (Locus Specific Probes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 15: Global: Fluorescent in Situ Hybridization Probe (Locus Specific Probes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 16: Global: Fluorescent in Situ Hybridization Probe (Alphoid/Centromeric Repeat Probes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 17: Global: Fluorescent in Situ Hybridization Probe (Alphoid/Centromeric Repeat Probes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 18: Global: Fluorescent in Situ Hybridization Probe (Whole Chromosome Probes) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 19: Global: Fluorescent in Situ Hybridization Probe (Whole Chromosome Probes) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 20: Global: Fluorescent in Situ Hybridization Probe (Flow FISH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 21: Global: Fluorescent in Situ Hybridization Probe (Flow FISH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 22: Global: Fluorescent in Situ Hybridization Probe (Q FISH) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 23: Global: Fluorescent in Situ Hybridization Probe (Q FISH) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 24: Global: Fluorescent in Situ Hybridization Probe (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 25: Global: Fluorescent in Situ Hybridization Probe (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 26: Global: Fluorescent in Situ Hybridization Probe (Cancer) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 27: Global: Fluorescent in Situ Hybridization Probe (Cancer) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 28: Global: Fluorescent in Situ Hybridization Probe (Genetic Diseases) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 29: Global: Fluorescent in Situ Hybridization Probe (Genetic Diseases) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 30: Global: Fluorescent in Situ Hybridization Probe (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 31: Global: Fluorescent in Situ Hybridization Probe (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 32: Global: Fluorescent in Situ Hybridization Probe (Research Organizations) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 33: Global: Fluorescent in Situ Hybridization Probe (Research Organizations) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 34: Global: Fluorescent in Situ Hybridization Probe (Diagnostic Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 35: Global: Fluorescent in Situ Hybridization Probe (Diagnostic Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 36: Global: Fluorescent in Situ Hybridization Probe (Others) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 37: Global: Fluorescent in Situ Hybridization Probe (Others) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 38: North America: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 39: North America: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 40: United States: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 41: United States: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 42: Canada: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 43: Canada: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 44: Asia Pacific: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 45: Asia Pacific: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 46: China: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 47: China: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 48: Japan: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 49: Japan: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 50: India: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 51: India: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 52: South Korea: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 53: South Korea: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 54: Australia: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 55: Australia: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 56: Indonesia: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 57: Indonesia: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 58: Others: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 59: Others: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 60: Europe: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 61: Europe: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 62: Germany: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 63: Germany: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 64: France: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 65: France: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 66: United Kingdom: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 67: United Kingdom: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 68: Italy: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 69: Italy: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 70: Spain: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 71: Spain: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 72: Russia: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 73: Russia: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 74: Others: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 75: Others: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 76: Latin America: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 77: Latin America: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 78: Brazil: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 79: Brazil: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 80: Mexico: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 81: Mexico: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 82: Others: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 83: Others: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 84: Middle East and Africa: Fluorescent in Situ Hybridization Probe Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 85: Middle East and Africa: Fluorescent in Situ Hybridization Probe Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 86: Global: Fluorescent in Situ Hybridization Probe Industry: SWOT Analysis
  • Figure 87: Global: Fluorescent in Situ Hybridization Probe Industry: Value Chain Analysis
  • Figure 88: Global: Fluorescent in Situ Hybridization Probe Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Fluorescent in Situ Hybridization Probe Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by Type (in Million US$), 2024-2032
  • Table 3: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by Probe Type (in Million US$), 2024-2032
  • Table 4: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 6: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 7: Global: Fluorescent in Situ Hybridization Probe Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 8: Global: Fluorescent in Situ Hybridization Probe Market: Competitive Structure
  • Table 9: Global: Fluorescent in Situ Hybridization Probe Market: Key Players
目次
Product Code: SR112024A2277

The global fluorescent in situ hybridization (FISH) probe market size reached US$ 872.9 Million in 2023. Looking forward, IMARC Group expects the market to reach US$ 1,512.7 Million by 2032, exhibiting a growth rate (CAGR) of 6.1% during 2024-2032. The increasing prevalence of genetic disorders, growing emphasis on early disease detection and screening, and extensive research and development (R&D) activities are some of the major factors propelling the market.

Fluorescent in situ hybridization (FISH) probe is a molecular biology technique used to visualize and map specific deoxyribonucleic acid (DNA) or ribonucleic acid (RNA) sequences within cells and tissues. They are composed of various materials, such as oligonucleotides, fluorophores, linkers and spacers, blocking reagents, and hybridization buffers. FISH probes are widely used in chromosomal abnormality detection, gene copy number variation analysis, oncology research, microbial identification, gene expression analysis, and prenatal diagnosis. They offer high sensitivity and resolution, allowing for the detection of even low-copy-number target sequences.

The increasing demand for personalized medicine is facilitating the adoption of FISH probes, as they provide valuable insights into individual patients' genetic profiles, enabling tailored treatment strategies based on their specific genetic alterations. Furthermore, the widespread utilization of FISH probes by clinicians and researchers to provide high-resolution visual and quantitative information about genetic abnormalities is providing an impetus to the market growth. Additionally, the implementation of supportive policies by several governments to reimburse patients for advanced diagnostic tests and provide access to high-quality healthcare facilities is strengthening the market growth. Other factors, including the rising geriatric population, the rapid expansion of the healthcare industry, extensive research and development (R&D) activities, rising focus on targeted therapies and increasing investment in the development of advanced FISH probes, are anticipated to drive the market growth.

Fluorescent in Situ Hybridization (FISH) Probe Market Trends/Drivers:

The increasing prevalence of genetic disorders

FISH probes are extensively used to detect structural abnormalities associated with genetic disorders, such as deletions, duplications, inversions, and translocations. Furthermore, they play a crucial role in the diagnosis of microdeletion and microduplication syndromes that are extremely difficult to detect under a standard microscope. Moreover, FISH probes enable the detection of repeat expansions, which aids in identifying Huntington's disease, fragile X syndrome, and myotonic dystrophy. Apart from this, they allow the assessment of gene copy number changes, thus aiding healthcare professionals in disease classification, predicting treatment response, and guiding personalized therapy decisions, which in turn is contributing to the market growth. Additionally, FISH probes provide information about carrier status, which allow individuals to make informed reproductive decisions and receive appropriate genetic counseling.

The growing emphasis on early disease detection and screening

FISH probes play a critical role in early cancer detection and diagnosis, as they can target specific genetic alterations commonly found in various cancers, including gene amplifications, deletions, translocations, and chromosomal rearrangements. Apart from this, they find applications in early diagnosis of infectious diseases caused by parasites, bacteria, or viruses. Moreover, FISH probes are extensively used in the timely detection of genetic conditions, such as Down syndrome, Turner syndrome, or Duchenne muscular dystrophy. Additionally, they are widely employed in prenatal diagnosis to detect chromosomal abnormalities in developing fetuses, which allows parents to make informed decisions about pregnancy and potential medical interventions.

Extensive research and development (R&D) activities

The introduction of multiplex FISH Probes, which allows the simultaneous detection of multiple genetic targets within a single sample, enabling researchers and clinicians to analyze multiple genomic regions in a single experiment, thus saving time and resources, is positively influencing the market growth. Furthermore, the recent development of proximity-FISH probes that enables the detection of spatial proximity between two or more genetic targets within a cell or tissue sample, thus providing valuable information about spatial interactions, gene clustering, and chromatin organization within cells, is contributing to the market growth. Moreover, the rapid digitalization of FISH Probe data, allowing for enhanced data sharing and automated image analysis, storage, and remote access, is supporting the market growth.

Fluorescent in Situ Hybridization (FISH) Probe Industry Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the global fluorescent in situ hybridization (FISH) probe market report, along with forecasts at the global, regional and country levels from 2024-2032. Our report has categorized the market based on type, probe type, technology, application, and end-user.

Breakup by Type:

DNA

RNA

mRNA

miRNA

Others

RNA dominates the market

The report has provided a detailed breakup and analysis of the market based on the type. This includes DNA and RNA (mRNA, miRNA, and others). According to the report, RNA represented the largest market segment.

RNA is dominating the market, as RNA FISH probes enable researchers to investigate gene expression patterns at the single-cell level, which provides valuable insights into cellular heterogeneity, developmental processes, and disease mechanisms. Furthermore, they enable the detection and visualization of non-coding RNAs (ncRNAs), such as microRNAs (miRNAs), circular RNAs (circRNAs), and long non-coding RNAs (lncRNAs), which aids in improving the understanding of the functions and regulatory networks of these important RNA molecules. Apart from this, RNA FISH Probes facilitate the real-time observation and tracking of RNA dynamics, such as RNA synthesis, degradation, and turnover rates, thus enabling researchers to study RNA biology and cellular response. Moreover, they offer high sensitivity and specificity in detecting RNA molecules by reducing background noise and false-positive signals.

Breakup by Probe Type:

Locus Specific Probes

Alphoid/Centromeric Repeat Probes

Whole Chromosome Probes

Locus specific probes hold the largest share in the market

The report has provided a detailed breakup and analysis of the market based on the probe type. This includes locus specific probes, alphoid/centromeric repeat probes, and whole chromosome probes. According to the report, locus specific probes accounted for the largest market share.

Locus-specific probes are designed to hybridize to specific genetic loci or regions of interest in the genome, which allows researchers and clinicians to focus on specific genes and chromosomal abnormalities associated with particular diseases and conditions. They also offer high diagnostic accuracy and precision by enabling the detection of specific genetic abnormalities with great specificity. Apart from this, Locus-specific probes are extensively used to detect and characterize genetic variations in patients, including chromosomal aberrations, microdeletions, and gene mutations.

Breakup by Technology:

Flow FISH

Q FISH

Others

Flow FISH dominates the market

The report has provided a detailed breakup and analysis of the market based on the technology. This includes flow FISH, Q FISH, and others. According to the report, flow FISH represented the largest market segment.

Flow FISH is dominating the market as it allows for rapid processing of a large number of cells, thus offering more data in a shorter amount of time compared to traditional FISH methods. Furthermore, it is known for its high sensitivity, which makes it ideal for detecting even low-abundance targets in medical diagnostics and research. In addition, flow FISH can be easily integrated with automation technologies to reduce manual errors and increase the throughput. Besides this, it provides quantitative data, which is crucial in fields such as healthcare, where precise measurements are required for diagnosis and treatment plans. Moreover, the cost per sample in flow FISH is less than traditional FISH methods, especially when analyzing large samples, making it highly appealing for both research and clinical settings.

Breakup by Application:

Cancer

Genetic Diseases

Others

Cancer dominates the market

The report has provided a detailed breakup and analysis of the market based on the application. This includes cancer, genetic diseases, and others. According to the report, cancer represented the largest market segment.

FISH probes are widely used in cancer treatment as they help to detect specific genetic abnormalities. It also enables healthcare professionals to identify and classify cancer cells, which further assist in diagnosis, prognosis, and treatment decision-making. Furthermore, they offer high specificity and sensitivity in detecting genetic aberrations and chromosomal rearrangements that are characteristic of various types of cancer. Apart from this, FISH probes aid oncologists in selecting the most appropriate targeted therapies and monitoring treatment response. They also assist in cancer research by improving the understanding of the underlying mechanism associated with cancer. Additionally, FISH probes are widely used in liquid biopsies to offer a non-invasive approach for cancer detection, monitoring, and treatment response assessment.

Breakup by End-User:

Research Organizations

Diagnostic Centers

Others

The report has provided a detailed breakup and analysis of the market based on the end-user. This includes flow research organizations, diagnostic centers, and others.

FISH probes are widely used in research organizations to enable the visualization and detection of specific DNA or RNA sequences within cells or tissues. They are used in gene mapping and chromosomal analysis, which aids in studying cancer genetics and identifying chromosomal rearrangements associated with specific malignancies. Furthermore, the FISH probe is extensively utilized in developmental biology and neurobiology to provide valuable insights into gene regulation, cellular development, and disease mechanisms.

Diagnostic centers extensively utilize FISH probes to identify genetic alterations in patient samples, which aids in diagnosing cancer, determining prognosis, and guiding treatment decisions. They also assist in genetic disease screening by detecting specific genetic abnormalities, such as aneuploidies and microdeletion syndromes. Apart from this, FISH probes are widely used in prenatal testing to screen for chromosomal abnormalities in developing fetuses.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America exhibits a clear dominance in the market, accounting for the largest fluorescent in situ hybridization (FISH) probe market share

The report has also provided a comprehensive analysis of all the major regional markets, which includes North America (the United States and Canada); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represented the largest market segment.

North America is dominating the FISH probe market owing to the strong focus on biomedical research in the region aimed at developing new diagnostic tools and molecular technologies. Additionally, the presence of a robust healthcare infrastructure comprising well-established hospitals, clinical laboratories, and diagnostic facilities is favoring the market growth. Moreover, the growing incidences of genetic disorders and cancer are facilitating the demand for accurate and reliable molecular diagnostic tools, such as FISH probes. Furthermore, the implementation of strict policies by regional governments to maintain the safety, efficacy, and quality of medical products and instruments is contributing to the market growth. Along with this, the presence of key players in the region that are equipped with resources and expertise to drive product development, marketing, and sales is positively influencing the market growth.

Competitive Landscape:

The top companies in the FISH probe market are actively engaged in developing new products by incorporating advanced technologies to improve the accuracy and reliability of results. In line with this, the significant investment in research and development (R&D) projects to expand their portfolio, gain competitive advantages, and meet rising consumer demand is favoring the market growth. Furthermore, several key players are adopting targeted marketing strategies by designing customized products that meet the unique requirements of users. Additionally, the increasing collaboration between leading companies, research institutions, and academic centers to jointly develop new FISH probe technologies, validate products through clinical studies, and strengthen market presence is contributing to the market growth. Moreover, several product manufacturers are establishing distribution channels, partnerships, and subsidiaries across the globe to expand their business and attract a new customer base.

The report has provided a comprehensive analysis of the competitive landscape in the global fluorescent in situ hybridization (FISH) probe market. Detailed profiles of all major companies have also been provided. Some of the key players in the market include:

Abnova Corporation

Agilent Technologies Inc.

Biocare Medical LLC

Biosearch Technologies (LGC Ltd.)

Creative Biolabs

F. Hoffmann-La Roche Ltd. (Roche Holding AG)

Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.)

Merck KGaA

Oxford Gene Technology (Sysmex Corporation)

PerkinElmer Inc.

ThermoFisher Scientific Inc.

Recent Developments:

In November 2022, Biocare Medical LLC announced the acquisition of Empire Genomics, a company that produces fluorescence in situ hybridization (FISH) probes designed and optimized for specific genes, diseases, or regions across the entire mouse and human genomes.

In March 2023, Oxford Gene Technology (Sysmex Corporation) announced that eight of its CytoCell FISH probes had been certified for clinical use in line with Europe's In Vitro Diagnostics Regulation (IVDR).

In April 2023, Agilent Technologies Inc. expanded its portfolio of SureFISH probes. This move was aimed at creating the largest offering of oligonucleotide-based fluorescent in situ hybridization (FISH) assays on the market.

Key Questions Answered in This Report:

  • How has the global fluorescent in situ hybridization (FISH) probe market performed so far, and how will it perform in the coming years?
  • What are the drivers, restraints, and opportunities in the global fluorescent in situ hybridization (FISH) probe market?
  • What is the impact of each driver, restraint, and opportunity on the global fluorescent in situ hybridization (FISH) probe market?
  • What are the key regional markets?
  • Which countries represent the most attractive fluorescent in situ hybridization (FISH) probe market?
  • What is the breakup of the market based on the type?
  • Which is the most attractive type in the fluorescent in situ hybridization (FISH) probe market?
  • What is the breakup of the market based on probe type?
  • Which is the most attractive probe type in the fluorescent in situ hybridization (FISH) probe market?
  • What is the breakup of the market based on technology?
  • Which is the most attractive technology in the fluorescent in situ hybridization (FISH) probe market?
  • What is the breakup of the market based on the application?
  • Which is the most attractive application in the fluorescent in situ hybridization (FISH) probe market?
  • What is the breakup of the market based on the end-user?
  • Which is the most attractive end-user in the fluorescent in situ hybridization (FISH) probe market?
  • What is the competitive structure of the global fluorescent in situ hybridization (FISH) probe market?
  • Who are the key players/companies in the global fluorescent in situ hybridization (FISH) probe market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Fluorescent in Situ Hybridization Probe Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Type

  • 6.1 DNA
    • 6.1.1 Market Trends
    • 6.1.2 Market Forecast
  • 6.2 RNA
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 mRNA
      • 6.2.2.2 miRNA
      • 6.2.2.3 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Probe Type

  • 7.1 Locus Specific Probes
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Alphoid/Centromeric Repeat Probes
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Whole Chromosome Probes
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Flow FISH
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Q FISH
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Others
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast

9 Market Breakup by Application

  • 9.1 Cancer
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Genetic Diseases
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Others
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast

10 Market Breakup by End-User

  • 10.1 Research Organizations
    • 10.1.1 Market Trends
    • 10.1.2 Market Forecast
  • 10.2 Diagnostic Centers
    • 10.2.1 Market Trends
    • 10.2.2 Market Forecast
  • 10.3 Others
    • 10.3.1 Market Trends
    • 10.3.2 Market Forecast

11 Market Breakup by Region

  • 11.1 North America
    • 11.1.1 United States
      • 11.1.1.1 Market Trends
      • 11.1.1.2 Market Forecast
    • 11.1.2 Canada
      • 11.1.2.1 Market Trends
      • 11.1.2.2 Market Forecast
  • 11.2 Asia Pacific
    • 11.2.1 China
      • 11.2.1.1 Market Trends
      • 11.2.1.2 Market Forecast
    • 11.2.2 Japan
      • 11.2.2.1 Market Trends
      • 11.2.2.2 Market Forecast
    • 11.2.3 India
      • 11.2.3.1 Market Trends
      • 11.2.3.2 Market Forecast
    • 11.2.4 South Korea
      • 11.2.4.1 Market Trends
      • 11.2.4.2 Market Forecast
    • 11.2.5 Australia
      • 11.2.5.1 Market Trends
      • 11.2.5.2 Market Forecast
    • 11.2.6 Indonesia
      • 11.2.6.1 Market Trends
      • 11.2.6.2 Market Forecast
    • 11.2.7 Others
      • 11.2.7.1 Market Trends
      • 11.2.7.2 Market Forecast
  • 11.3 Europe
    • 11.3.1 Germany
      • 11.3.1.1 Market Trends
      • 11.3.1.2 Market Forecast
    • 11.3.2 France
      • 11.3.2.1 Market Trends
      • 11.3.2.2 Market Forecast
    • 11.3.3 United Kingdom
      • 11.3.3.1 Market Trends
      • 11.3.3.2 Market Forecast
    • 11.3.4 Italy
      • 11.3.4.1 Market Trends
      • 11.3.4.2 Market Forecast
    • 11.3.5 Spain
      • 11.3.5.1 Market Trends
      • 11.3.5.2 Market Forecast
    • 11.3.6 Russia
      • 11.3.6.1 Market Trends
      • 11.3.6.2 Market Forecast
    • 11.3.7 Others
      • 11.3.7.1 Market Trends
      • 11.3.7.2 Market Forecast
  • 11.4 Latin America
    • 11.4.1 Brazil
      • 11.4.1.1 Market Trends
      • 11.4.1.2 Market Forecast
    • 11.4.2 Mexico
      • 11.4.2.1 Market Trends
      • 11.4.2.2 Market Forecast
    • 11.4.3 Others
      • 11.4.3.1 Market Trends
      • 11.4.3.2 Market Forecast
  • 11.5 Middle East and Africa
    • 11.5.1 Market Trends
    • 11.5.2 Market Breakup by Country
    • 11.5.3 Market Forecast

12 SWOT Analysis

  • 12.1 Overview
  • 12.2 Strengths
  • 12.3 Weaknesses
  • 12.4 Opportunities
  • 12.5 Threats

13 Value Chain Analysis

14 Porters Five Forces Analysis

  • 14.1 Overview
  • 14.2 Bargaining Power of Buyers
  • 14.3 Bargaining Power of Suppliers
  • 14.4 Degree of Competition
  • 14.5 Threat of New Entrants
  • 14.6 Threat of Substitutes

15 Price Indicators

16 Competitive Landscape

  • 16.1 Market Structure
  • 16.2 Key Players
  • 16.3 Profiles of Key Players
    • 16.3.1 Abnova Corporation
      • 16.3.1.1 Company Overview
      • 16.3.1.2 Product Portfolio
      • 16.3.1.3 Financials
    • 16.3.2 Agilent Technologies Inc.
      • 16.3.2.1 Company Overview
      • 16.3.2.2 Product Portfolio
      • 16.3.2.3 Financials
      • 16.3.2.4 SWOT Analysis
    • 16.3.3 Biocare Medical LLC
      • 16.3.3.1 Company Overview
      • 16.3.3.2 Product Portfolio
    • 16.3.4 Biosearch Technologies (LGC Ltd.)
      • 16.3.4.1 Company Overview
      • 16.3.4.2 Product Portfolio
    • 16.3.5 Creative Biolabs
      • 16.3.5.1 Company Overview
      • 16.3.5.2 Product Portfolio
    • 16.3.6 F. Hoffmann-La Roche Ltd (Roche Holding AG)
      • 16.3.6.1 Company Overview
      • 16.3.6.2 Product Portfolio
      • 16.3.6.3 SWOT Analysis
    • 16.3.7 Genemed Biotechnologies Inc. (Sakura Finetek USA Inc.)
      • 16.3.7.1 Company Overview
      • 16.3.7.2 Product Portfolio
    • 16.3.8 Merck KGaA
      • 16.3.8.1 Company Overview
      • 16.3.8.2 Product Portfolio
      • 16.3.8.3 Financials
      • 16.3.8.4 SWOT Analysis
    • 16.3.9 Oxford Gene Technology (Sysmex Corporation)
      • 16.3.9.1 Company Overview
      • 16.3.9.2 Product Portfolio
      • 16.3.9.3 Financials
    • 16.3.10 PerkinElmer Inc.
      • 16.3.10.1 Company Overview
      • 16.3.10.2 Product Portfolio
      • 16.3.10.3 Financials
      • 16.3.10.4 SWOT Analysis
    • 16.3.11 ThermoFisher Scientific Inc.
      • 16.3.11.1 Company Overview
      • 16.3.11.2 Product Portfolio
      • 16.3.11.3 Financials
      • 16.3.11.4 SWOT Analysis